Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
GLP-1 agonists primarily reduce appetite and slow digestion, leading to reduced calorie intake
Neelakantan H, Vance V, Wetzel MD, et al
NAD+ declines naturally with age, contributing to reduced cellular function, decreased energy production, and impaired DNA repair
NAD+ IV Therapy involves a slow intravenous infusion that usually takes longer and is often chosen for deeper, extended sessions
Lancet 387 (10026), 13771396
As GLOW has no trial-established dose, the derived range is 1.4-4.2 mg per injection: Low Dose: 1.4 mg (1 mg GHK-Cu + 200 mcg BPC-157 + 200 mcg TB-4) Standard Dose: 2.8 mg (2 mg GHK-Cu + 400 mcg BPC-157 + 400 mcg TB-4) Elevated Dose: 4.2 mg (3 mg GHK-Cu + 600 mcg BPC-157 + 600 mcg TB-4) What is the GLOW dose per day
US$ 29.88
US$ 25.91
US$ 28.21
US$ 22.71
US$ 24.64
